Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Gerlach

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Journal of Experimental Medicine|May 8, 2002
The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compoundSoerge Kelm, Judith Gerlach, Reinhard Brossmer, et al.
European Journal of Immunology|February 6, 2002
Reduction of marginal zone B cells in CD22-deficient miceTatjana Samardzic, Dragan Marinkovic, Claus-Peter Danzer, et al.
European Journal of Immunology|September 11, 2002
CD22 regulates early B cell development in BOB.1/OBF.1-deficient miceTatjana Samardzic, Judith Gerlach, Kerstin Muller, et al.
European Journal of Immunology|November 25, 2003
B cell defects in SLP65/BLNK-deficient mice can be partially corrected by the absence of CD22, an inhibitory coreceptor for BCR signalingJudith Gerlach, Snigdha Ghosh, Hassan Jumaa, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Journal of Experimental Medicine|May 8, 2002
The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compoundSoerge Kelm, Judith Gerlach, Reinhard Brossmer, et al.
European Journal of Immunology|February 6, 2002
Reduction of marginal zone B cells in CD22-deficient miceTatjana Samardzic, Dragan Marinkovic, Claus-Peter Danzer, et al.
European Journal of Immunology|September 11, 2002
CD22 regulates early B cell development in BOB.1/OBF.1-deficient miceTatjana Samardzic, Judith Gerlach, Kerstin Muller, et al.
European Journal of Immunology|November 25, 2003
B cell defects in SLP65/BLNK-deficient mice can be partially corrected by the absence of CD22, an inhibitory coreceptor for BCR signalingJudith Gerlach, Snigdha Ghosh, Hassan Jumaa, et al.
Pageof 1